HIV HCV Coinfection Antiviral Therapy and Fibrosis

HIV HCV 合并感染抗病毒治疗和纤维化

• 批准号: 9066124
• 负责人: David L Thomas
• 金额: $ 72.62万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-06-01 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9066124
• 关键词: Acquired Immunodeficiency Syndrome; Affect; Age Distribution; Antibodies; Antiviral Therapy; Archives; Baltimore; Bedside Testings; Birth; Bone Diseases; CD4 Positive T Lymphocytes; Cardiovascular Diseases; Caring; Centers for Disease Control and Prevention (U.S.); Central Nervous System Diseases; Chronic Disease; Chronic Hepatitis C; Cities; Client; Clinic; Clinical Trials; Collaborations; Communities; Computerized Medical Record; Counseling; Data; Devices; Diabetes Mellitus; Disease; Ecology; Economics; Effectiveness; Ensure; FDA approved; Fatty Liver; Fellowship; Fibrosis; Foundations; Funding; Genetic Transcription; Genotype; Goals; Grant; HIV; HIV Infections; HIV antiretroviral; HIV/HCV; Health; Health Services; Hepatic; Hepatitis C; Hepatitis C Antibodies; Hepatitis C Prevalence; Hepatitis C co-infection; Hepatitis C virus; Hospitals; Human; Immune; Incidence; Individual; Infection; Injecting drug user; Insurance Carriers; Interferon-alpha; Interferons; Laboratories; Link; Liver; Liver Fibrosis; Liver diseases; Lymphocyte Depletion; Measurement; Measures; Medical; Medicine; Metabolic; Methods; Molecular Profiling; Monitor; Morbidity - disease rate; Nature; Notification; Osteoporosis; Outcome; Outcome Study; Paper; Pathogenesis; Patients; Peripheral Blood Mononuclear Cell; Persons; Pharmaceutical Preparations; Phase; Phenotype; Physician Executives; Plasma; Population; Prevalence; Progress Reports; Protease Inhibitor; Public Health; Publishing; RNA; Recommendation; Recruitment Activity; Research; Research Personnel; Resources; Role; Running; Safety; Seminal; Series; Services; Sexually Transmitted Diseases; Source; Spottings; Testing; Therapeutic; Tissues; Treatment Efficacy; United States National Institutes of Health; United States Public Health Service; Venipunctures; Virus Diseases; Virus Replication; Work; abstracting; antiretroviral therapy; base; burden of illness; clinical practice; co-infection; cohort; efficacy testing; elastography; falls; high risk; immune activation; improved; inhibitor/antagonist; insight; interest; medical schools; mortality; nonhuman primate; novel; outreach; phase 3 study; predicting response; resistance mutation; response; restoration; standard of care; success; tenure track; transmission process; treatment duration; treatment strategy; trend; uptake; viral RNA; viral resistance

No Abstract provided.

未提供摘要。